Logo image of SGRP

SPAR GROUP INC (SGRP) Stock Fundamental Analysis

NASDAQ:SGRP - Nasdaq - US7849331035 - Common Stock - Currency: USD

1.05  -0.01 (-0.94%)

Fundamental Rating

2

SGRP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 97 industry peers in the Media industry. The financial health of SGRP is average, but there are quite some concerns on its profitability. SGRP is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SGRP has reported negative net income.
SGRP had a negative operating cash flow in the past year.
In multiple years SGRP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SGRP reported negative operating cash flow in multiple years.
SGRP Yearly Net Income VS EBIT VS OCF VS FCFSGRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

SGRP has a worse Return On Assets (-5.58%) than 62.89% of its industry peers.
SGRP has a Return On Equity (-12.96%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.58%
ROE -12.96%
ROIC N/A
ROA(3y)-0.67%
ROA(5y)0%
ROE(3y)-0.75%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
SGRP Yearly ROA, ROE, ROICSGRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Gross Margin, with a value of 19.54%, SGRP is doing worse than 75.26% of the companies in the same industry.
SGRP's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SGRP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y0.05%
SGRP Yearly Profit, Operating, Gross MarginsSGRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

SGRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
SGRP has less shares outstanding than it did 1 year ago.
SGRP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SGRP has a worse debt to assets ratio.
SGRP Yearly Shares OutstandingSGRP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SGRP Yearly Total Debt VS Total AssetsSGRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

SGRP has an Altman-Z score of 4.45. This indicates that SGRP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.45, SGRP belongs to the best of the industry, outperforming 85.57% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that SGRP is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, SGRP perfoms like the industry average, outperforming 51.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 4.45
ROIC/WACCN/A
WACC8.51%
SGRP Yearly LT Debt VS Equity VS FCFSGRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

SGRP has a Current Ratio of 1.53. This is a normal value and indicates that SGRP is financially healthy and should not expect problems in meeting its short term obligations.
SGRP's Current ratio of 1.53 is in line compared to the rest of the industry. SGRP outperforms 58.76% of its industry peers.
A Quick Ratio of 1.53 indicates that SGRP should not have too much problems paying its short term obligations.
SGRP has a Quick ratio (1.53) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
SGRP Yearly Current Assets VS Current LiabilitesSGRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SGRP have decreased strongly by -159.41% in the last year.
The Revenue for SGRP has decreased by -25.09% in the past year. This is quite bad
Measured over the past years, SGRP shows a decrease in Revenue. The Revenue has been decreasing by -4.89% on average per year.
EPS 1Y (TTM)-159.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-366.67%
Revenue 1Y (TTM)-25.09%
Revenue growth 3Y-8.36%
Revenue growth 5Y-4.89%
Sales Q2Q%-49.24%

3.2 Future

The Earnings Per Share is expected to grow by 112.71% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y221.19%
EPS Next 2Y112.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGRP Yearly Revenue VS EstimatesSGRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SGRP Yearly EPS VS EstimatesSGRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

SGRP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.58, the valuation of SGRP can be described as very reasonable.
SGRP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SGRP is cheaper than 77.32% of the companies in the same industry.
SGRP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 8.58
SGRP Price Earnings VS Forward Price EarningsSGRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SGRP is valued a bit cheaper than the industry average as 69.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.24
SGRP Per share dataSGRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

SGRP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGRP's earnings are expected to grow with 112.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.71%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPAR GROUP INC

NASDAQ:SGRP (6/20/2025, 8:00:02 PM)

1.05

-0.01 (-0.94%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-16 2025-05-16/amc
Earnings (Next)08-12 2025-08-12
Inst Owners11.02%
Inst Owner Change-17.79%
Ins Owners1.36%
Ins Owner Change-0.07%
Market Cap24.62M
Analysts82.86
Price TargetN/A
Short Float %1.46%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-712.74%
Min EPS beat(2)-1276.47%
Max EPS beat(2)-149.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.36%
Min Revenue beat(2)-16.94%
Max Revenue beat(2)-11.79%
Revenue beat(4)2
Avg Revenue beat(4)9.81%
Min Revenue beat(4)-16.94%
Max Revenue beat(4)40.3%
Revenue beat(8)3
Avg Revenue beat(8)3.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.58
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.09
EV/EBITDA 7.24
EPS(TTM)-0.1
EYN/A
EPS(NY)0.12
Fwd EY11.66%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS8.39
BVpS1.04
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.58%
ROE -12.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.54%
FCFM N/A
ROA(3y)-0.67%
ROA(5y)0%
ROE(3y)-0.75%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y0.05%
F-Score3
Asset Turnover3.49
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA 14.95
Cap/Depr 70.48%
Cap/Sales 0.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 4.45
F-Score3
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)73.74%
Cap/Depr(5y)75.81%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-159.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-366.67%
EPS Next Y221.19%
EPS Next 2Y112.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.09%
Revenue growth 3Y-8.36%
Revenue growth 5Y-4.89%
Sales Q2Q%-49.24%
Revenue Next Year-16.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.73%
OCF growth 3YN/A
OCF growth 5YN/A